Why it matters
The program could affect companies and researchers developing neuroscience products, but the announcement provides no details about expected effects on product availability, costs or patients.
HEALTH POLICY & CARE • UNITED STATES
FDA launches program to support neuroscience medical-product development
This brief summarizes public reporting and official announcements. Research findings may be preliminary. Talk to a qualified clinician before making health decisions.
This event has left the current brief. The summary below describes the stored record; open the original sources for current conditions.
BLUF
The FDA has launched the Neuroscience Advancement and Innovation Nexus, a program intended to advance development of neuroscience medical products. The announcement does not specify particular products, timelines or approvals.
HOW THIS BRIEF WAS MADE 1 outlet: 1 official. Automated sourcing and summaries by the BLUF engine. Corrections